These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 16305066)
1. Diabetes mellitus and vascular risk: continuing the quest for the elusive keystone. Marso SP Diab Vasc Dis Res; 2005 Feb; 2(1):7-8. PubMed ID: 16305066 [No Abstract] [Full Text] [Related]
2. Pathobiology and cell interactions of platelets in diabetes. Stratmann B; Tschoepe D Diab Vasc Dis Res; 2005 Feb; 2(1):16-23. PubMed ID: 16305068 [TBL] [Abstract][Full Text] [Related]
3. Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Colwell JA Metabolism; 1992 May; 41(5 Suppl 1):7-10. PubMed ID: 1574016 [No Abstract] [Full Text] [Related]
4. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment. Mathewkutty S; McGuire DK Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262 [TBL] [Abstract][Full Text] [Related]
5. Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implications. Schneider DJ Rev Cardiovasc Med; 2007; 8 Suppl 3():S35-41. PubMed ID: 17917620 [TBL] [Abstract][Full Text] [Related]
6. The proinflammatory and hypercoagulable state of diabetes mellitus. Aras R; Sowers JR; Arora R Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731 [TBL] [Abstract][Full Text] [Related]
12. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity. Price MJ Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982 [No Abstract] [Full Text] [Related]
13. Introducing the 2019 ESC Guidelines on Diabetes, Pre-Diabetes, and CVD. Aboyans V Eur Heart J; 2019 Oct; 40(39):3217-3219. PubMed ID: 31608953 [No Abstract] [Full Text] [Related]
14. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease. Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424 [TBL] [Abstract][Full Text] [Related]
15. PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients. Crescente M; Di Castelnuovo A; Iacoviello L; de Gaetano G; Cerletti C Thromb Haemost; 2008 Jun; 99(6):1129-31. PubMed ID: 18521524 [No Abstract] [Full Text] [Related]